During the past decade, Hillsboro Cardiology, PC conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hillsboro Cardiology, PC" #1 sponsor was "Bristol-Myers Squibb" with 2 trials, followed by "Forest Laboratories" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Abbott" with 1 trials sponsored and "Cogentus Pharmaceuticals" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hillsboro Cardiology, PC" #1 collaborator was "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator, "ClinLogix. LLC" with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator, "Orion Corporation, Orion Pharma" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hillsboro Cardiology, PC" are "Atrial Fibrillation" (4 trials), "Hypertension" (2 trials), "Acute Coronary Syndrome" (1 trials), "Angina Pectoris" (1 trials) and "Atrial Flutter" (1 trials). Many other conditions were trialed in "Hillsboro Cardiology, PC" in a lesser frequency.

Most popular intervention types in "Hillsboro Cardiology, PC" are "Drug" (11 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Azimilide Dihydrochloride" (2 trials), "Darusentan" (2 trials), "Acetylsalicylic acid" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hillsboro Cardiology, PC" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Hillsboro Cardiology, PC". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hillsboro Cardiology, PC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hillsboro Cardiology, PC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".